Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
Int. j. high dilution res ; 21(1): 11-11, May 6, 2022.
Article in English | LILACS, HomeoIndex Homeopathy | ID: biblio-1396584

ABSTRACT

Arnica montana 6CH is a medicine indicated for inflammatory and painful conditions, especially in muscle structures. The RDC / TMD Axis II questionnaire is a validated tool for the diagnosis of Temporomandibular Muscle Dysfunction. Objective: This multicenter, randomized and controlled study, approved by Human or Animal Research Ethics Committee UniFOA -CAAE: 48680015.3.0000.5237 aimed to verify the clinical performance of Arnica montana 6CH in contractures and muscle pain triggered by isometric stress. Materials and Methods: 70 patients underwent prolongeddental treatment sessions, and they were selected after clinical examination and positive responses to the RDC / TMD questionnaire to confirm signs and symptoms of Temporomandibular Muscle Dysfunction at the first consultation. Randomly, Arnica montana 6CH was prescribed for 35 patients called group I, and placebo for 35 patients called group II, at a dose of 5 globules, 03 times a day, for 1 week. In the second endodontic consultation, after 15 days, a new clinical examination was performed at the beginning and end of the prolonged dental consultation with crossing of data from the RDC questionnaire, to monitor the prevalence of TMD muscle signs and symptoms. The data were tabulated and analyzed. Statistical analysis: The test t de Student was used for paired samples, significant at the level ≤ 0.05%. Results:Anamnetic data from the RDC questionnaire, 86% of the individuals in the GI had lower pain and muscle contracture rates in the second consultation, compared with 22% in the GII. Conclusion:The drug Arnica montana 6CH proved to be effective in preventing muscle changes and clinical symptoms resulting from isometric efforts with a statistically significant difference (p ≤ 0.05).


Subject(s)
Humans , Arnica , Oral Surgical Procedures/rehabilitation , Myalgia/therapy , Thermography
2.
J Clin Exp Dent ; 14(1): e35-e39, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35070122

ABSTRACT

BACKGROUND: The treatment of dentin before the use of self-adhesive cements is still a crucial point to achieve the best bond strength values. The objective of this study was to evaluate the bond strength between dentin and composite resin using different adhesion strategies with self-adhesive resin cement. MATERIAL AND METHODS: Forty healthy third human molars were randomly divided into 4 groups (n = 10): CA (control); application of self-adhesive cement (Rely X U200, 3M ESPE), AD + CA: only application of conventional adhesive (Adper Single Bond 2, 3M ESPE) + self-adhesive cement, AC + AD + CA; conditioning with 37% phosphoric acid for 15 seconds + application of conventional adhesive + self-adhesive cement and AC + CA; conditioning with 37% phosphoric acid for 15s + self-adhesive cement. Blocks made of composite resin (Z250 XT, 3M ESPE) were cemented over dentin. The samples were stored for 24h in distilled water at 37ºC and then were sectioned on a metallographic cutter to obtain tooth picks with approximately 1.0 mm2 in cross section. A universal testing machine was used with a speed of 0.5 mm/min to test the microtensile bond strength,. The fracture patterns were classified as adhesive, cohesive and mixed failures. The data (MPa) were analyzed statistically by One-way ANOVA and Holm-Sidak test (α=5%). RESULTS: The AC + AD + CA and AC + CA groups had the highest averages, while the CA and AD + CA groups had the lowest bond strength values. Adhesive failure was prevalent in all groups. CONCLUSIONS: Conditioning with 37% phosphoric acid for 15s increases the adhesion of the self-adhesive resin cement to the dentin, regardless of the use of dental adhesive system. Key words:Resin cement, microtensile bond strength, acid conditioning.

3.
J Endod ; 30(1): 42-4, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14760907

ABSTRACT

The purpose of this study was to determine if citric-acid solutions for endodontic use can become contaminated and if the addition of a microbiological stabilizer to the acid would modify this situation. Five types of microorganisms were inoculated in tubes containing 10% citric-acid solutions, pH 1.8 (group A1), and 10% solution, pH 1.8, combined with 0.1% sodium benzoate (group A2). The results demonstrated that solutions of group A1 were contaminated with Candida albicans in 100% of the tubes, Escherichia coli in 80%, and Enterococcus faecalis in 50%. When stabilizer was added (group A2), C. albicans grew in only 30% of tubes and all bacterial species were neutralized.


Subject(s)
Anti-Infective Agents/pharmacology , Citric Acid/pharmacology , Drug Contamination/prevention & control , Preservatives, Pharmaceutical/pharmacology , Root Canal Irrigants/pharmacology , Sodium Benzoate/pharmacology , Anti-Infective Agents/chemistry , Bacillus subtilis/drug effects , Bacillus subtilis/growth & development , Candida albicans/drug effects , Candida albicans/growth & development , Citric Acid/chemistry , Colony Count, Microbial , Enterococcus faecalis/drug effects , Enterococcus faecalis/growth & development , Escherichia coli/drug effects , Escherichia coli/growth & development , Humans , Hydrogen-Ion Concentration , Preservatives, Pharmaceutical/chemistry , Root Canal Irrigants/chemistry , Sodium Benzoate/chemistry , Streptococcus mutans/drug effects , Streptococcus mutans/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL